Overweight , Obesity: Clinical Trials

62 trials for Overweight , Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 not yet recruiting, 17 recruiting, 15 completed, 9 active not recruiting. 31 Not applicable, 10 Phase 2, 9 Phase 1, 5 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable31Recruiting 12, Not yet recruiting 9, Completed 6, Active not recruiting 3, Withdrawn 1
Phase 210Active not recruiting 4, Completed 3, Recruiting 2, Not yet recruiting 1
Phase 19Completed 3, Not yet recruiting 3, Recruiting 2, Active not recruiting 1
Phase 35Not yet recruiting 3, Active not recruiting 1, Recruiting 1
Phase 42Not yet recruiting 2

Follow Overweight , Obesity: new trials by email Literature Review of Overweight , Obesity trials Research Report on Overweight , Obesity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents
A 10-week multicomponent camp intervention for children, A BED intervention for parents - Binge Eating Disorder, Binge Eating
Not applicableNot yet recruitingUniversity of Aarhus2002027-01-012026-04-13
Dietary Guidelines for Americans-Ultra Processed Study
Low-processed DGA Diet, Ultra-processed DGA Diet - Overweight , Obesity, Class I Obesity
Not applicableWithdrawnUSDA Grand Forks Human Nutrition Research Center2026-12-012026-08-07
I-OPERA: A European Study Testing a New Way to Do Health Research.
Obesity (Disorder), Overweight , Obesity
Not yet recruitingIQVIA RDS Spain, SL1052026-11-012026-08-12
Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
Bupropion 150 mg, Lyophilized powder from edible mushrooms, Lifestyle Management - Cardiometabolic Syndrome, Obesity and Cardiovascular Risk
Phase 3Not yet recruitingUppsala University2502026-10-302026-09-08
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
Semaglutide, Placebo - Type 1 Diabetes, Overweight , Obesity
Phase 2 / Phase 3RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre402026-10-132026-10-23
Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for Post-Operative Analgesia in Patients Undergoing Bariatric Surgery
Tegileridine (tegileridine fumarate injection, IV), Sufentanil - Pain Management, Overweight , Obesity
Phase 3Not yet recruitingThe First Hospital of Jilin University1482026-10-012026-10-16
TRPTI Metabolic and GLP-1 Pharmacodynamic Study
TRPTI, Placebo - Overweight , Obesity
Phase 4Not yet recruitingRDC Clinical Pty Ltd202026-10-012026-09-30
Community Physical Exercise Program in Chronic Disease
Physical Exercise - Osteoarthritis Pain, Myocardial Infarction (MI)
Not applicableNot yet recruitingAssociação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv1502026-10-012026-09-10
Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study
Stair-Climbing Exercise Snacks - Overweight , Obesity
Not applicableRecruitingSt. Louis University122026-10-012026-09-30
Study of UBT37034 Injection
UBT37034, Placebo - Overweight , Obesity
Phase 1Not yet recruitingThe United Bio-Technology (Hengqin) Co., Ltd.402026-10-012026-10-14
A Trial to Examine the Effects of a Weight Loss Program Emphasizing Protein, Dietary Fiber, and Exercise (30-30-30 Plan)
30-30-30 PFE Intervention, Standard - Overweight , Obesity
Not applicableRecruitingMidwest Center for Metabolic and Cardiovascular Research1102026-09-232026-10-05
Standardized Large Yellow Tea Extract for Glucose and Lipid Metabolism in Overweight Adults With Hypertriglyceridemia
Standardized Large Yellow Tea Extract, Placebo - Hypertriglyceridemia, Overweight , Obesity
Not applicableNot yet recruitingThe First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)1382026-09-012026-09-25
Long-term Follow-up After Childhood Obesity
The AFTER study - Assessing Future Trajectories of hEalth- and well-being among childhood obesity treatment Recipients - Overweight , Obesity
Not yet recruitingUlla Toft61002026-09-012026-10-05
Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity
MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity
Phase 3Not yet recruitingShanghai Minwei Biotechnology Co., Ltd7602026-09-012026-08-21
Exercise, Chronotype, and Prediabetes
Timing of exercise, Control - Prediabetes, Overweight , Obesity
Not applicableRecruitingGerman Diabetes Center282026-09-012026-09-11
Combining Fasting and Fibre Interventions to Optimise Their Gut Microbiome-mediated Health Benefits
Fibre Arm, Control Arm - Fasting, Dietary Fibre
Not applicableRecruitingBuchinger Wilhelmi Development & Holding GmbH752026-08-312026-09-30
Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants
MWN110, Placebo - Overweight , Obesity
Phase 1Not yet recruitingShanghai Minwei Biotechnology Co., Ltd1032026-08-262026-08-24
Impact of Antioxidant-rich Supplementation on Skin Carotenoids Status, Antioxidant Status and Cardiometabolic Health in Overweight and Obese Individuals
Antioxidant-rich supplementation Element, Antioxidant-rich supplementation Optimal - Overweight , Obesity, Antioxidant Status
Not applicableNot yet recruitingNational University of Singapore832026-08-152026-08-05
BfedBwell INSPIRE Pilot
BfedBwell - Core Curriculum, BfedBwell - 1:1 Counseling, BfedBwell - Behavioral Skills - Cancer Survivorship, Overweight , Obesity
Not applicableActive not recruitingUniversity of Colorado, Denver162026-08-112026-09-03
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
ALV-100, Placebo - Overweight , Obesity, Adults
Phase 2RecruitingAlveus Therapeutics, Inc.2202026-08-102026-10-26

Showing 20 of 62. Sign in to see all of them.

Narrower conditions

Obesity (62)  ·  Overweight (62)  ·  Motor Activity (6)  ·  Diabetes Mellitus, Type 2 (4)  ·  Hypertension (4)  ·  Weight Loss (4)  ·  Metabolic Syndrome (3)  ·  Pediatric Obesity (3)  ·  Prediabetic State (3)  ·  Diabetes Mellitus (2)  ·  Inflammation (2)  ·  Abdominal obesity metabolic syndrome (1)  ·  Agnosia (1)  ·  Anxiety Disorders (1)  ·  Binge-Eating Disorder (1)

Broader conditions

Body Weight (62)  ·  Nutrition Disorders (62)  ·  Nutritional and Metabolic Diseases (62)  ·  Overnutrition (62)  ·  Pathological Conditions, Signs and Symptoms (62)  ·  Signs and Symptoms (62)  ·  Metabolic Diseases (13)  ·  Glucose Metabolism Disorders (11)  ·  Endocrine System Diseases (10)  ·  Behavior (9)  ·  Diabetes Mellitus (7)  ·  Cardiovascular Diseases (5)  ·  Vascular Diseases (5)  ·  Body Weight Changes (4)  ·  Pathologic Processes (4)

Interventions

Exercise (2)  ·  Bupropion (1)  ·  Caloric Restriction (1)  ·  Counseling (1)  ·  Diet Therapy (1)  ·  Educational Status (1)  ·  Metformin (1)  ·  Probiotics (1)  ·  Resistance Training (1)  ·  Saline Solution (1)  ·  Sucrose (1)  ·  Sufentanil (1)  ·  Synbiotics (1)  ·  Tirzepatide (1)  ·  asiaticoside (1)

Sponsors

Shanghai Minwei Biotechnology Co., Ltd (11)  ·  Beijing QL Biopharmaceutical Co.,Ltd (3)  ·  Alveus Therapeutics, Inc. (1)  ·  Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv (1)  ·  Beijing Anzhen Hospital (1)  ·  Buchinger Wilhelmi Development & Holding GmbH (1)  ·  Cairo University (1)  ·  China National Center for Cardiovascular Diseases (1)  ·  ClostraBio Inc. (1)  ·  Federal University of Health Science of Porto Alegre (1)  ·  Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1)  ·  German Diabetes Center (1)  ·  He Eye Hospital (1)  ·  IQVIA RDS Spain, SL (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)

Countries

China (23)  ·  United States (9)  ·  Australia (3)  ·  Germany (2)  ·  Netherlands (2)  ·  Singapore (2)  ·  Spain (2)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Greece (1)  ·  Israel (1)  ·  Italy (1)  ·  Malaysia (1)

Top investigators

Linong Ji, MD (2)  ·  Aihua Zhang, MD. (1)  ·  Andrea Siegler, Dr. med. (1)  ·  Aristea Gioxari (1)  ·  Cory Schwartz, PhD (1)  ·  Emily Hill, PhD, RDN (1)  ·  Fei Meng, MD (1)  ·  Fernanda M Busnello, PhD (1)  ·  Hossein Rafiei, PhD, RD (1)  ·  Hui-Chuan Huang, Ph.D (1)  ·  Jan Eriksson, MD, PhD (1)  ·  Jens M Bruun, Professor (1)  ·  Jie Yu, Master (1)

Results publications

PMID 29650080, PMID 30591697, PMID 35055821, PMID 35472434, PMID 37246231, PMID 38001776, PMID 39199206, PMID 40049186, PMID 41365300, PMID 42356368